编者按：乳腺癌患者或许可以通过接受放疗，来避免因切除腋窝（腋下）淋巴结手术后可能发生的淋巴水肿。日前于西班牙巴塞罗那举行的第15届欧洲乳腺癌会议（EBCC-15）上公布的ADARNAT研究的新发现表明，腋窝放疗在清除任何残留癌细胞方面可能同样有效，同时引发淋巴水肿（一种常表现为手臂和腋窝疼痛性肿胀的症状）的可能性更低。 这些结果来自一项国际随机Ⅲ期临床试验（ADARNAT研究）的初步阶段[1, 2 ...

Skipping standard axillary lymph node dissection led to very low rates of axillary recurrence in patients with node-positive breast cancer who became node-negative following neoadjuvant chemotherapy, ...

Neoadjuvant dose-dense anthracycline and cyclophosphamide in combination with carboplatin, paclitaxel, and pembrolizumab for triple-negative breast cancer: A systematic review and meta-analysis. This ...

The word “dissection” may conjure images of a high school biology lab full of frogs or sheep’s eyeballs in various stages of deconstruction. But an axillary node dissection is a decidedly different ...

Targeted axillary dissection (TAD) is a relatively new breast cancer procedure. It allows surgical oncologists to specifically locate a lymph node that contained cancer before chemotherapy, remove it ...

A prognostic miRNA based signature in early-stage HER2-positive breast cancer patients. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I. This abstract does not include a full text ...

We read with interest the Article by Giacomo Montagna and colleagues1 evaluating oncological outcomes in patients with residual nodal micrometastatic disease (ypN1mi) following neoadjuvant systemic ...

MIAMI BEACH -- The surgical dogma favoring axillary dissection in breast cancer continues to give way to more selective data-driven strategies that allow more women to avoid axillary surgery, an ...

Ten-year findings suggest some patients may safely receive less treatment, potentially lowering side effects without raising ...

Recently, omission of axillary lymph node dissection among patients with early breast cancer has been found to have no detrimental effect on outcomes in most cases, continuing a trend toward less ...

Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — Omission of completion axillary lymph node dissection did not increase recurrence among patients ...